ADG20 potential for Covid-19 treatment, prevention
KUALA LUMPUR: Adagio Therapeutics Inc, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialisation of antibody-based solutions for infectious diseases with pandemic potential, has announced new